• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 在恶性胸膜间皮瘤中的失调与预后相关,并提示细胞代谢的改变。

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.

机构信息

Respiratory Research Division, Department of Medicine, Education and Research Centre, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland.

Immuno-Oncology Laboratory, Department of Paediatric Haematology/Oncology, Ospedale Pediatrico Bambino Gesù, Viale di S. Paolo 15, 00146, Rome, Italy.

出版信息

Sci Rep. 2017 Jun 9;7(1):3140. doi: 10.1038/s41598-017-02694-0.

DOI:10.1038/s41598-017-02694-0
PMID:28600498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5466648/
Abstract

Malignant pleural mesothelioma (MPM) is an aggressive human cancer and miRNAs can play a key role for this disease. In order to broaden the knowledge in this field, the miRNA expression was investigated in a large series of MPM to discover new pathways helpful in diagnosis, prognosis and therapy. We employed nanoString nCounter system for miRNA profiling on 105 MPM samples and 10 healthy pleura. The analysis was followed by the validation of the most significantly deregulated miRNAs by RT-qPCR in an independent sample set. We identified 63 miRNAs deregulated in a statistically significant way. MiR-185, miR-197, and miR-299 were confirmed differentially expressed, after validation study. In addition, the results of the microarray analysis corroborated previous findings concerning miR-15b-5p, miR-126-3p, and miR-145-5p. Kaplan-Meier curves were used to explore the association between miRNA expression and overall survival (OS) and identified a 2-miRNA prognostic signature (Let-7c-5p and miR-151a-5p) related to hypoxia and energy metabolism respectively. In silico analyses with DIANA-microT-CDS highlighted 5 putative targets in common between two miRNAs. With the present work we showed that the pattern of miRNAs expression is highly deregulated in MPM and that a 2-miRNA signature can be a new useful tool for prognosis in MPM.

摘要

恶性胸膜间皮瘤(MPM)是一种侵袭性人类癌症,miRNA 可以在其中发挥关键作用。为了拓宽该领域的知识,我们对大量 MPM 样本进行了 miRNA 表达谱分析,以发现有助于诊断、预后和治疗的新途径。我们采用了 nanoString nCounter 系统对 105 个 MPM 样本和 10 个健康胸膜进行 miRNA 分析。对最显著失调的 miRNA 进行了 RT-qPCR 验证,验证样本集是独立的。我们鉴定了 63 个 miRNA 在统计学上显著失调。miR-185、miR-197 和 miR-299 经过验证研究后,被证实差异表达。此外,微阵列分析的结果证实了 miR-15b-5p、miR-126-3p 和 miR-145-5p 的先前发现。Kaplan-Meier 曲线用于探索 miRNA 表达与总生存期(OS)之间的关联,并确定了一个与缺氧和能量代谢相关的 2miRNA 预后特征(Let-7c-5p 和 miR-151a-5p)。DIANA-microT-CDS 的计算分析突出了两个 miRNA 之间的 5 个可能的共同靶标。通过本研究,我们表明 MPM 中 miRNA 表达模式高度失调,2miRNA 特征可以成为 MPM 预后的新有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/5466648/0cb2f2dde54e/41598_2017_2694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/5466648/1060b2237e38/41598_2017_2694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/5466648/0cb2f2dde54e/41598_2017_2694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/5466648/1060b2237e38/41598_2017_2694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d1/5466648/0cb2f2dde54e/41598_2017_2694_Fig2_HTML.jpg

相似文献

1
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.miRNAs 在恶性胸膜间皮瘤中的失调与预后相关,并提示细胞代谢的改变。
Sci Rep. 2017 Jun 9;7(1):3140. doi: 10.1038/s41598-017-02694-0.
2
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.钾钙激活通道亚基α1(KCa1.1)是miR-17-5p的作用靶点,并调节恶性胸膜间皮瘤中的细胞迁移。
Mol Cancer. 2016 Jun 1;15(1):44. doi: 10.1186/s12943-016-0529-z.
3
In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.计算机转录组学分析恶性胸膜间皮瘤中与伤口愈合相关的基因。
Medicina (Kaunas). 2019 Jun 12;55(6):267. doi: 10.3390/medicina55060267.
4
Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.恶性胸膜间皮瘤、胸膜炎症和非典型间皮增生中微小RNA表达特征分析揭示了常见的预测肿瘤发生相关靶点。
Exp Mol Pathol. 2014 Dec;97(3):375-85. doi: 10.1016/j.yexmp.2014.09.016. Epub 2014 Sep 16.
5
MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.MiR评分:一种预测恶性胸膜间皮瘤患者生存结局的新型6-微RNA特征。
Mol Oncol. 2015 Mar;9(3):715-26. doi: 10.1016/j.molonc.2014.11.007. Epub 2014 Dec 2.
6
Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.miR-126、miR-143、miR-145和miR-652在恶性胸膜间皮瘤中的诊断潜力
J Mol Diagn. 2014 Jul;16(4):418-30. doi: 10.1016/j.jmoldx.2014.03.002. Epub 2014 Jun 6.
7
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.在曾接触石棉的工人和胸膜间皮瘤患者中发现循环微RNA失调,可作为潜在的新型生物标志物。
Oncotarget. 2016 Dec 13;7(50):82700-82711. doi: 10.18632/oncotarget.12408.
8
Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.微小RNA在石棉暴露与恶性间皮瘤中的诊断价值:系统评价与定性荟萃分析
Oncotarget. 2016 Sep 6;7(36):58606-58637. doi: 10.18632/oncotarget.9686.
9
ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.ZIC1 在恶性胸膜间皮瘤中被沉默并具有肿瘤抑制功能。
J Thorac Oncol. 2013 Oct;8(10):1317-28. doi: 10.1097/JTO.0b013e3182a0840a.
10
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.在恶性间皮瘤中,CDKN2A、NF2和JUN等基因被微小RNA(miRNA)失调——一项miRNA微阵列分析。
Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669.

引用本文的文献

1
microRNA-497-5p-based screening identifies a novel synthetic lethal-type interaction via PKMYT1 and WEE1 in pleural mesothelioma.基于微小RNA-497-5p的筛选在胸膜间皮瘤中通过PKMYT1和WEE1鉴定出一种新型的合成致死型相互作用。
Mol Ther Nucleic Acids. 2025 Jun 17;36(3):102610. doi: 10.1016/j.omtn.2025.102610. eCollection 2025 Sep 9.
2
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets.恶性胸膜间皮瘤:从病理生理学到创新的可操作靶点
Cancers (Basel). 2025 Mar 30;17(7):1160. doi: 10.3390/cancers17071160.
3
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.

本文引用的文献

1
MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice.微小RNA-299-5p通过神经元自噬调节细胞凋亡,并改善APPswe/PS1dE9小鼠的认知能力。
Sci Rep. 2016 Apr 15;6:24566. doi: 10.1038/srep24566.
2
MiR-15b mediates liver cancer cells proliferation through targeting BCL-2.微小RNA-15b通过靶向B细胞淋巴瘤-2(BCL-2)介导肝癌细胞增殖。
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15677-83. eCollection 2015.
3
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
胸膜间皮瘤(PMe):一种罕见且侵袭性癌症的不断发展的分子知识。
Mol Oncol. 2024 Apr;18(4):797-814. doi: 10.1002/1878-0261.13591. Epub 2024 Mar 8.
4
ATG5 as biomarker for early detection of malignant mesothelioma.ATG5 作为恶性间皮瘤早期检测的生物标志物。
BMC Res Notes. 2023 Apr 24;16(1):61. doi: 10.1186/s13104-023-06330-1.
5
The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints.恶性胸膜间皮瘤中基因-干性-分泌组的相互作用:分子动力学与临床提示
Int J Mol Sci. 2023 Feb 9;24(4):3496. doi: 10.3390/ijms24043496.
6
Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma.定义上皮样恶性胸膜间皮瘤的两个分子亚型。
Cells. 2022 Sep 19;11(18):2924. doi: 10.3390/cells11182924.
7
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects.间皮瘤治疗的新见解:新兴途径与未来前景
Front Oncol. 2022 Jun 17;12:916839. doi: 10.3389/fonc.2022.916839. eCollection 2022.
8
Serum Expression Levels of Certain miRNAs in Predicting Diagnosis, Prognosis, and Response to Chemotherapy in Malignant Pleural Mesothelioma.血清中某些 miRNA 的表达水平在预测恶性胸膜间皮瘤的诊断、预后和化疗反应中的作用。
Balkan Med J. 2022 Jul 22;39(4):246-254. doi: 10.4274/balkanmedj.galenos.2022.2022-3-26. Epub 2022 Jun 13.
9
Long Non-coding RNA HOXA11-AS Facilitates Proliferation of Lung Adenocarcinoma Cells Targeting the Let-7c-5p/IGF2BP1 Axis.长链非编码RNA HOXA11-AS通过靶向Let-7c-5p/IGF2BP1轴促进肺腺癌细胞增殖
Front Genet. 2022 Mar 17;13:831397. doi: 10.3389/fgene.2022.831397. eCollection 2022.
10
Effects of hsa-mir-145-5p on the Regulation of msln Expression in Colorectal Adenocarcinoma.hsa-mir-145-5p 对结直肠腺癌中 msln 表达调控的影响。
Anal Cell Pathol (Amst). 2022 Mar 15;2022:5587084. doi: 10.1155/2022/5587084. eCollection 2022.
贝伐珠单抗治疗新诊断的胸膜间皮瘤的 Mesothelioma Avastin Cisplatin Pemetrexed 研究(MAPS):一项随机、对照、开放标签、3 期临床试验。
Lancet. 2016 Apr 2;387(10026):1405-1414. doi: 10.1016/S0140-6736(15)01238-6. Epub 2015 Dec 21.
4
Mitochondria-related miR-151a-5p reduces cellular ATP production by targeting CYTB in asthenozoospermia.线粒体相关的miR-151a-5p通过靶向细胞色素b降低弱精子症患者细胞的ATP生成。
Sci Rep. 2015 Dec 2;5:17743. doi: 10.1038/srep17743.
5
MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.在非小细胞肺癌细胞中,miR-185通过靶向AKT1发挥肿瘤抑制作用。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11854-62. eCollection 2015.
6
Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer.微小RNA对缺氧诱导因子-血管内皮生长因子通路调控的计算模型:对缺血性血管疾病和癌症病理生理学的见解
PLoS Comput Biol. 2015 Nov 20;11(11):e1004612. doi: 10.1371/journal.pcbi.1004612. eCollection 2015 Nov.
7
MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.MiR-145是一种靶向ADAM17的微小RNA,可抑制鼻咽癌细胞的侵袭和迁移。
Exp Cell Res. 2015 Nov 1;338(2):232-8. doi: 10.1016/j.yexcr.2015.08.006. Epub 2015 Aug 20.
8
MiR-126 regulated breast cancer cell invasion by targeting ADAM9.微小RNA-126通过靶向解聚素金属蛋白酶9调控乳腺癌细胞侵袭。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6547-53. eCollection 2015.
9
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy.癌症中的微小RNA:从发现到治疗之路的历史视角
Cancers (Basel). 2015 Jul 27;7(3):1388-405. doi: 10.3390/cancers7030842.
10
TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185.TRIM29在胃癌中作为一种癌基因发挥作用,并受miR-185调控。
Int J Clin Exp Pathol. 2015 May 1;8(5):5053-61. eCollection 2015.